Trial Profile
A study evaluating correlation between EZH2 expression and efficacy of Tazemetostat in pediatric patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Tazemetostat (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 04 Sep 2017 New trial record